Trading Intuitive Surgical's Earnings (ISRG, ARAY)

Intuitive Surgical ISRG is set to report earnings tonight and Wall Street is looking for earnings of $2.25 per share on revenues of $367.65 million in revenues. Analysts are looking for Intuitive Surgical to report guidance of $2.36 per share on revenues of $377.34 million. If Intuitive Surgical reports better than expected numbers and guides higher, Accuray ARAY should move higher, as it's a direct competitor of Intuitive Surgical. We could also see other names like Johnson & Johnson JNJ, and Stryker SYK move higher, as the pin action from Intuitive Surgical is likely to be fairly large. Analysts will also look to see what backlog Intuitive Surgical has for the da Vinci system, which is the primary revenue driver for ISRG. Analysts will also be looking to see what Intuitive Surgical has to say about its deal with Cardica CRDC, where it received the exclusive global license to Cardica's intellectual property, related to tissue cutting, stapling and clip appliers for application in the robotics field. At last check, shares of Intuitive Surgical were down $2.15 to $288.30, a loss of 0.74%. Intuitive Surgical engages in the design, manufacture, and marketing of da Vinci surgical systems for use in urologic, gynecologic, cardiothoracic, general, and head and neck surgeries.